Compounds > u 69593
Page last updated: 2024-08-26

u 69593 and amphetamine

u 69593 has been researched along with amphetamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's5 (62.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inderbitzin, S; Lauber, ME; Lichtensteiger, W; Schlumpf, M1
Partridge, B; Schenk, S; Shippenberg, TS1
Gray, AM; McGinty, JF; Rawls, SM; Shippenberg, TS1
De Vries, TJ; Schoffelmeer, AN; Vanderschuren, LJ; Wardeh, G1
Partridge, B; Schenk, S1
McGinty, JF; Tzaferis, JA1
He, L; Hjelmstad, GO; Whistler, JL; Xia, YF1
Andrés, ME; Fuentealba, JA; Gysling, K1

Other Studies

8 other study(ies) available for u 69593 and amphetamine

ArticleYear
Amphetamine-induced preprodynorphin mRNA expression and kappa-opioid receptor binding in basal ganglia of adult rats after prenatal exposure to diazepam.
    Brain research. Developmental brain research, 1997, Jan-02, Volume: 98, Issue:1

    Topics: Age Factors; Amphetamine; Analgesics; Animals; Basal Ganglia; Benzeneacetamides; Binding, Competitive; Diazepam; Dynorphins; Female; GABA Modulators; Gene Expression; In Situ Hybridization; Male; Pregnancy; Prenatal Exposure Delayed Effects; Protein Precursors; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa; RNA, Messenger; Sympathomimetics; Tritium

1997
U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking.
    Psychopharmacology, 1999, Volume: 144, Issue:4

    Topics: Amphetamine; Animals; Behavior, Addictive; Benzeneacetamides; Cocaine-Related Disorders; Dopamine Antagonists; Dopamine Uptake Inhibitors; Flupenthixol; Male; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Administration

1999
The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum.
    Journal of neurochemistry, 1999, Volume: 73, Issue:3

    Topics: Amphetamine; Animals; Behavior, Animal; Benzeneacetamides; Calcium; Dopamine; Glutamic Acid; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Neostriatum; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa

1999
Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Psychopharmacology, 2000, Volume: 150, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amphetamine; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Central Nervous System Stimulants; Cocaine; Male; Motor Activity; Psychomotor Agitation; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa

2000
Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior.
    Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:4

    Topics: Amphetamine; Analgesics; Animals; Behavior, Addictive; Benzeneacetamides; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Administration

2001
Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum.
    Brain research. Molecular brain research, 2001, Sep-10, Volume: 93, Issue:1

    Topics: Amphetamine; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Central Nervous System Stimulants; Corpus Striatum; Dynorphins; Enkephalins; Gene Expression; In Situ Hybridization; Male; Neuropeptides; Protein Precursors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Stimulation, Chemical; Substance P

2001
Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:4

    Topics: Amphetamine; Analgesics, Opioid; Analysis of Variance; Animals; Benzeneacetamides; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Male; Narcotic Antagonists; Nucleus Accumbens; Patch-Clamp Techniques; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa

2008
Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
    Synapse (New York, N.Y.), 2007, Volume: 61, Issue:9

    Topics: Amphetamine; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Benzeneacetamides; Central Nervous System Stimulants; Drug Administration Schedule; Drug Synergism; Male; Microdialysis; Motor Activity; Pyrrolidines; Rats; Rats, Sprague-Dawley; Time Factors

2007